Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Targeted Oncology, (2023), 18, 1, (9-24), 10.1007/s11523-022-00941-7)
- Sanjay Popat
- , Myung Ju Ahn
- , Simon Ekman
- , Natasha B. Leighl
- , Suresh S. Ramalingam
- , Thanyanan Reungwetwattana
- , Shankar Siva
- , Masahiro Tsuboi
- , Yi Long Wu
- , James Chih Hsin Yang
- Royal Marsden NHS Foundation Trust
- Institute of Cancer Research
- Sungkyunkwan University
- Karolinska Institutet
- Princess Margaret Cancer Centre
- Emory University
- Mahidol University
- Peter Maccallum Cancer Centre
- University of Melbourne
- National Cancer Center Japan
- Guangdong Academy of Medical Sciences
- National Taiwan University
Research output: Contribution to journal › Comment/debate